Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Diadexus Inc (DDXS)

Diadexus Inc (DDXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Diadexus Inc 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080

www.diadexus.com P: 650-246-6400

Description:

DiaDexus, Inc. operates as a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease. The Company's patented product PLAC Test for Lp-PLA2, identifies hidden risk for heart attack and stroke. The PLAC Test is the only blood test cleared by the FDA to assess risk for coronary heart disease and ischemic stroke associated with atherosclerosis. DiaDexus, Inc. is headquartered in San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 80
Shares Outstanding, K 4,100
Annual Sales, $ 18,110 K
Annual Net Income, $ -7,170 K
Last Quarter Sales, $ 3,530 K
Last Quarter Net Income, $ -1,690 K
60-Month Beta 0.82
% of Insider Shareholders 4.42%
% of Institutional Shareholders 0.00%

Growth:

1-Year Return -99.71%
3-Year Return -99.89%
5-Year Return -99.72%
5-Year Revenue Growth 54.13%
5-Year Earnings Growth -51.20%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 05/10/16
Earnings Per Share ttm -1.99
EPS Growth vs. Prev Qtr -10.81%
EPS Growth vs. Prev Year -36.74%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 07/01/15

DDXS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -55.48%
Profit Margin % -39.59%
Debt/Equity 0.00
Price/Sales 0.00
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.53
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar